GlassScriptPhysician profile
Jose Luciano
NPI 1578640876
$11,578.31
in general payments reported to CMS, 2019-2025
51 companies · $1,847 in 2025
The $1,847 reported for 2025 was more than what 86% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,873 · 2020: $1,320 · 2021: $1,279 · 2022: $1,511 · 2023: $1,806 · 2024: $1,942 · 2025: $1,847.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,575 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,575.01 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,725.20 | 2019-2025 | Tezspire, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $1,499.99 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $943.69 | 2019-2025 | Ofev, Jascayd, Spiriva Respimat |
| Insmed, INC. | $900.37 | 2019-2025 | Arikayce, Brinsupri |
| Actelion Pharmaceuticals US, INC. | $839.60 | 2019-2025 | Uptravi, Opsumit |
| United Therapeutics Corporation | $461.76 | 2019-2025 | Tyvaso, Tyvaso, Orenitram |
| Bayer Healthcare Pharmaceuticals INC. | $423.45 | 2019-2025 | |
| Amgen INC. | $346.67 | 2021-2025 | Tezspire, Tavneos |
| Regeneron Healthcare Solutions, INC. | $315.21 | 2019-2024 | Dupixent |
| Genzyme Corporation | $310.43 | 2019-2025 | |
| Mylan Specialty L.P. | $297.91 | 2019-2023 | Yupelri |
| Grifols USA, LLC | $289.32 | 2022-2025 | Prolastin-C Liquid |
| Takeda Pharmaceuticals U.S.A., INC. | $281.21 | 2021-2025 | Glassia |
| Intuitive Surgical, INC. | $229.77 | 2022-2023 | Da Vinci Surgical System |
| Gilead Sciences, INC. | $219.76 | 2019-2025 | Biktarvy |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $216.91 | 2020-2024 | |
| Sunovion Pharmaceuticals INC. | $182.78 | 2019-2020 | |
| Shionogi INC | $178.73 | 2020-2024 | Fetroja |
| Abbvie INC. | $168.27 | 2022-2025 | |
| Pulmonx Corporation | $159.49 | 2019-2025 | Chartis Catheter, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Genentech USA, INC. | $157.34 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $152.67 | 2020-2025 | Winrevair, Recarbrio, Zerbaxa |
| Baxter Healthcare | $136.52 | 2022-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Monarch Airway Clearance System, Hillrom - Life 2000 Ventilation System |
| Jazz Pharmaceuticals INC. | $135.33 | 2019-2022 | |
| Pfizer INC. | $100.43 | 2019-2024 | |
| Electromed, INC. | $76.50 | 2019-2025 | Smartvest |
| Portola Pharmaceuticals, LLC | $65.60 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $61.87 | 2019-2023 | Xarelto |
| Covis Pharma Gmbh | $58.88 | 2022 | |
| Vapotherm INC | $56.59 | 2022 | |
| Allergan, INC. | $56.23 | 2019-2020 | |
| Viatris Specialty LLC | $55.08 | 2025 | Yupelri |
| Abiomed | $44.80 | 2024 | Impella |
| Advanced Respiratory, INC | $41.80 | 2019-2020 | |
| Phadia US INC. | $31.94 | 2019-2025 | Immunocap |
| Sandoz INC. | $31.71 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $30.72 | 2021-2022 | |
| Verona Pharma, INC. | $29.97 | 2025 | Ohtuvayre |
| Paratek Pharmaceuticals, INC. | $29.17 | 2020-2021 | |
| Inspire Medical Systems, INC. | $28.96 | 2024 | Inspire |
| Philips North America LLC | $28.48 | 2019 | |
| Mallinckrodt Hospital Products INC. | $27.91 | 2023 | Acthar |
| Inogen, INC. | $27.13 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $25.81 | 2019 | |
| Novartis Pharmaceuticals Corporation | $24.84 | 2019 | |
| Ambu INC. | $20.29 | 2024 | |
| Nuwellis, INC. | $15.01 | 2020 | |
| Circassia INC. | $12.84 | 2019 | |
| Eisai INC. | $12.62 | 2021 | |
| Biomerieux INC | $10.75 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Luciano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.